Yvonne Fors - 16 Sep 2022 Form 4 Insider Report for THERALINK TECHNOLOGIES, INC.

Role
Director
Signature
/s/ Yvonne Fors
Issuer symbol
THER on OTC
Transactions as of
16 Sep 2022
Net transactions value
$0
Form type
4
Filing time
22 Sep 2022, 16:54:34 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THER Stock Option (right to buy) Award $0 +6,488,851 $0.000000 6,488,851 16 Sep 2022 Common Stock 6,488,851 $0.003600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 2,595,540 of the stock options will become exercisable upon the filing by the corporation of an S-8 registration statement covering its 2022 Equity Incentive Plan. The remaining 3,893,311 stock options will vest ratably on January 1, 2023, January 1, 2024 and January 1, 2025.